Validation and Verification: The Dynamic Duo of Medical Device Safety | Valkit.ai
Validation and Verification: The Dynamic Duo of Medical Device Safety
Learn how validation medical device processes ensure safety with our guide on verification vs validation, regulatory standards, and best practices.
Steve Ferrell·
Introduction
Medical device validation is the structured process of establishing objective evidence that a finished device consistently fulfills user needs, clinical intent, and safety requirements under actual or simulated use conditions. While engineering verification confirms whether a device meets technical specifications, validation proves that the final product performs safely and effectively in the hands of clinical users.
Bringing a medical technology to market requires balancing innovation with strict compliance. The Contract Development and Manufacturing Market reached $100 Billion in 2025 (growing at an 11.4% CAGR), driven significantly by rising regulatory burdens and the global harmonization of verification and validation expectations. To succeed in this landscape, understanding how each piece of the quality lifecycle fits together is indispensable.
Design Verification vs. Design Validation: Understanding the Difference
It is easy to mix up verification and validation—both start with the letter "V" and both involve rigorous testing against technical criteria. However, confusing the two within your Design History File (DHF) or Technical Documentation will stall an audit.
The classic distinction boils down to two simple questions:
Verification: Did you design the device right? (Does design output meet design input?)
Validation: Did you design the right device? (Does the device meet user needs and clinical intent?)
Characteristic Design Verification Design Validation Primary Question Did we build the product correctly? Did we build the correct product? Evaluation Basis Specified engineering inputs and technical drawings User needs, clinical intent, and operational environment Test Environment Controlled laboratories, test benches, simulation models Simulated clinical environments or actual clinical settings Test Subject Prototypes, sub-assemblies, finished parts Initial production units (or production equivalents) Dimensional analysis, bench testing, FEA, stress tests Usability testing, human factors studies, clinical trials Specific components or functional subsystems Complete product system (including labeling, IFU, packaging) 21 CFR 820.30(f) / ISO 13485 Clause 7.3.6 21 CFR 820.30(g) / ISO 13485 Clause 7.3.7
A vital regulatory detail that catches many engineering teams off-guard is that design validation must be performed on initial production units or their equivalents. You cannot validate a commercial medical device solely using early 3D-printed lab prototypes assembled by your R&D engineers. Regulators want objective evidence that devices built on actual manufacturing lines, by standard production personnel using approved work instructions, fulfill clinical requirements consistently.
Methods for Executing Design Verification
Design verification confirms that technical design outputs match engineering design inputs. We break down verification methods into four primary categories:
Physical and Mechanical Bench Testing: Direct testing of physical parameters such as tensile strength, fatigue life, catheter burst pressure, torque resistance, and electrical safety under standard operating stress.
Inspection and Dimensional Measurement: Utilizing optical comparators, coordinate measuring machines (CMM), and calipers to verify that physical dimensions remain strictly within tight engineering tolerances.
Analytical Modeling and Simulation: Employing Finite Element Analysis (FEA) and Computational Fluid Dynamics (CFD) to predict stress concentrations, thermal dissipation, or fluid dynamics before cutting metal or running physical protocols.
Software Verification: Executing automated unit testing, integration tests, static code analysis, and boundary condition checks against defined software architecture specifications.
To see practical examples of how engineering teams structure physical and simulated testing protocols, review our guide on Medical Device Design Validation.
Methods for Executing Design Validation
Design validation focuses on real-world utility, clinical effectiveness, and user ergonomics. The main methods include:
Clinical Investigations and Evaluations: Direct evaluation of clinical safety and effectiveness in human subjects or through systematic clinical literature evaluations demonstrating equivalence.
Human Factors and Usability Studies: Conducting summative usability assessments with representative users (e.g., nurses, patients, surgeons) in high-fidelity simulated environments to ensure the interface does not induce critical use errors.
Simulated Use and Environmental Testing: Subjecting devices to realistic environmental variables—including electromagnetic interference, transport vibration, temperature swings, and ambient clinical noise.
Packaging and Sterilization Validation: Confirming that the sterile barrier maintains seal integrity across simulated shelf life and transit conditions.
Under EU MDR Annex II Section 6, manufacturers must document comprehensive pre-clinical and clinical verification and validation test reports mapped directly to the General Safety and Performance Requirements (GSPRs). According to the Team-NB Position Paper, the two leading causes of Notified Body assessment delays are incomplete submissions and poor, fragmented documentation structure.
Notified Bodies do not accept abbreviated summaries, uncontrolled continuous integration logs, or fragmented iteration notes. Reviewers expect complete, unified test reports that cite test specifications, sample sizes, calibrated equipment, clear pass/fail criteria, and formal sign-offs.
Integrating ISO 14971 Risk Management into Validation
Validation does not exist in a vacuum—it is directly tied to risk management under ISO 14971. Regulators follow a strict risk control hierarchy:
Inherent Safety by Design: Eliminate hazards completely through design modifications.
Protective Measures: Incorporate automated safety systems, physical guards, or alarms for uneliminable risks.
Information for Safety: Provide clear warnings, contraindications, and user training.
Every single risk mitigation control identified in your Failure Mode and Effects Analysis (FMEA) must link bidirectionally to a corresponding verification or validation record. When an auditor samples your technical documentation, they frequently work bottom-up: selecting a high-severity hazard from the risk table and tracing it straight to the objective test record proving the mitigation works.
To explore overarching validation architectures that unify risk controls and testing, read our overview of Medical Device Validation.
Process Validation: When Verification Alone Is Not Enough
While design validation confirms your device design satisfies user needs, process validation confirms your manufacturing line consistently turns out conforming products.
The fundamental rule of process validation is straightforward: When the output of a manufacturing process cannot be fully or practically verified by subsequent non-destructive inspection and testing, the process must be validated.
Think of the classic matchstick analogy: To verify whether a match works, you must strike it. But striking it destroys the product. Because 100% destructive testing on finished commercial units is impossible, you must validate the process parameters (chemical composition, wood density, dip time, drying temperature) to guarantee that every match will light reliably.
Common manufacturing processes requiring mandatory validation include:
Sterile barrier heat sealing (blister packs and Tyvek pouches)
Ethylene oxide (EO), gamma irradiation, and steam sterilization cycles
Automated injection molding and ultrasonic welding
Automated liquid filling and reagent mixing
Adhesive curing and automated component swaging
Process Validation Medical Device Requirements in Manufacturing
Process validation follows a structured three-stage lifecycle:
Installation Qualification (IQ): Confirms that equipment is delivered, installed, wired, plumbed, and configured strictly according to supplier specifications and safety codes.
Operational Qualification (OQ): Challenges the operating parameters at upper and lower process limits ("worst-case" conditions) to ensure the machinery operates reliably within acceptable process windows.
Performance Qualification (PQ): Demonstrates that the integrated process, using qualified materials, operators, and environmental cleanroom conditions, consistently produces conforming units across multiple production runs.
Determining statistically sound sample sizes based on risk level and confidence intervals is mandatory prior to running PQ protocols. For an in-depth breakdown of regulatory expectations, review our guide on FDA Guidance on Process Validation for Medical Devices.
Specialized Validation: Software, SaMD, and Laboratory-Developed Tests
As digital health technologies and automated diagnostics accelerate, specialized validation requirements apply to computerized systems and diagnostic workflows across regional health authorities, such as those Regulating medical devices in the UK.
Under international standards such as ISO 15189 and IEC 62304, software-driven medical devices and diagnostic platforms require rigorous validation protocols tailored to their functional architecture.
Software and LDT Validation Medical Device Protocols
Medical software validation falls into two primary categories: Software in a Medical Device (SiMD) and standalone Software as a Medical Device (SaMD). Governed by IEC 62304, software development must establish lifecycle traceability spanning software safety classifications (Class A, B, or C).
Modern regulatory frameworks under EU MDR Annex I Section 17 explicitly mandate that medical software incorporate cybersecurity, information security, and performance verification across its entire operational lifecycle. Uncontrolled Continuous Integration (CI) outputs are insufficient on their own; regulated software releases demand formal, pre-approved test plans with recorded outcomes and electronic sign-offs. For detailed execution strategies, see our deep-dive on Software Validation Medical Device.
In clinical laboratory environments, distinct requirements govern FDA-cleared commercial in vitro diagnostic (IVD) systems versus Laboratory-Developed Tests (LDTs):
FDA-Approved / Cleared IVD Systems: When a clinical diagnostic facility adopts an already approved commercial instrument, the laboratory typically conducts verification to confirm that the assay performs according to the manufacturer's published performance specifications within their local testing environment.
Laboratory-Developed Tests (LDTs): If a clinical facility designs, modifies, or develops an in-house assay, the laboratory must perform full analytical and clinical validation. This includes establishing analytical sensitivity, analytical specificity, reportable range, precision, accuracy, carryover potential, and sample stability.
When establishing reference intervals for diagnostic parameters, the Clinical and Laboratory Standards Institute (CLSI) provides clear statistical criteria:
Establishing a new reference range: CLSI recommends testing a minimum of 120 patient samples to calculate statistically robust reference thresholds.
Verifying a published reference range: A laboratory can verify an established reference range using 40 samples (20 from healthy men and 20 from healthy women). The published range is accepted if at least 95% of test results fall within the documented boundaries; if fewer than 95% comply, the facility must establish its own 120-sample reference range.
Best Practices to Overcome Common Validation Challenges
Medical device manufacturers routinely face validation bottlenecks, ranging from documentation bloat to broken traceability. Implementing structured best practices eliminates these inefficiencies:
Eliminate Documentation Bloat (Subtract to Ship): Up to 40% of technical documentation files often consist of superseded early prototype test runs, unverified exploratory studies, and duplicate records. Pruning redundant draft reports streamlines Notified Body reviews.
Maintain Strict Bidirectional Traceability: Never rely on unstable page numbers or file directory paths. Use standardized requirement IDs, risk IDs, and test protocol IDs across your Traceability Matrix.
Define Testable Design Inputs Upfront: Unambiguous, quantifiable design inputs prevent subjective testing failures. An input must specify exact tolerances, environmental parameters, and measurable units.
Incorporate Human Factors Early: Conduct iterative formative usability evaluations throughout product development rather than waiting for a single summative usability test at the end.
Adopt Digital Validation Platforms: Manual, paper-based validation execution is highly vulnerable to transcription errors, missing signatures, and versioning drift.
Transitioning to automated systems eliminates these administrative burdens. Using an AI-driven digital platform such as Medical Device Validation Software streamlines protocol creation, test execution, and compliance tracking. At Valkit.ai, our platform reduces validation costs by up to 80% and cuts execution cycles from weeks to hours via automated workflows, intelligent cloning, and automated compliance tools.
Frequently Asked Questions About Medical Device Validation
What is the primary difference between medical device verification and validation?
Design verification establishes objective evidence that design outputs meet specified engineering design inputs ("Did we build the device right?"). Design validation establishes objective evidence that the finished medical device satisfies user needs, clinical intent, and intended uses under realistic operating conditions ("Did we build the right device?").
When is manufacturing process validation mandatory for medical devices?
Process validation is mandatory whenever a manufacturing process produces outputs that cannot be fully or practically verified by subsequent non-destructive inspection and testing. Classic examples include sterile packaging heat sealing, ethylene oxide sterilization, cleanroom adhesive bonding, and automated plastic injection molding.
How many samples are needed to establish versus verify a reference range in laboratory testing?
According to CLSI guidelines, establishing a new reference range requires testing a minimum of 120 patient samples. Verifying an existing, published reference range requires 40 samples (20 healthy men and 20 healthy women), with an acceptance threshold of at least 95% of results falling within the published range.
Conclusion
Medical device verification and validation represent the cornerstone of patient safety and market success. Verification guarantees that your engineering outputs adhere to rigorous technical specifications, while design and process validation ensure that your finished device delivers consistent, error-free clinical outcomes in the hands of real-world users.
Navigating FDA design controls, ISO 13485 QMS alignment, ISO 14971 risk management, and EU MDR Annex II technical requirements requires absolute data integrity and end-to-end traceability. By shifting away from cumbersome paper binders and disconnected spreadsheets toward modern digital workflows, development teams can de-risk their regulatory submissions, eliminate audit delays, and bring life-changing medical innovations to market faster.
To discover how intelligent digital automation can transform your validation lifecycle, explore the capabilities of Valkit.ai.
